"[Express Scripts], of course,
was the remaining pure play. I think what's kind of prevailing right now is
this notion that the PBMs are really starting to kind of attach their value to
a larger ecosystem."
— Ashraf Shehata, a partner at
KPMG's Global Healthcare Center of Excellence, tells Radar on Drug Benefits
about Cigna Corp.'s agreement to acquire Express Scripts Holding Co.
No comments:
Post a Comment